Track the Lexicon Pharmaceuticals, INC. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Lexicon Pharmaceuticals, INC. has recorded 77 public disclosures. Market capitalisation: €943.9m. The latest transaction was filed on 13 May 2025 (Levée d'options). Among the most active insiders: COATS LONNEL. The full history is openly available.
77
Insider Decl.
0
Thresholds
€119m
17 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lexicon Pharmaceuticals, INC. Buy (bullish), based on 5 analysts. Average price target: US$3.72.
32Σ signal
Buys €119m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 17,969 of 25,567 companies
38.3
score / 100
Value
20
Quality
57
FCF yld-6.6%
Earn yld-4.9%
EV/EBITDA·
ROE-16%
Gross mgn99%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.